Guardant Health
GH
#1183
Rank
A$28.41 B
Marketcap
A$214.27
Share price
-1.59%
Change (1 day)
207.73%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): A-$5.06

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$4.85. In 2025 the company made an earnings per share (EPS) of A-$4.73 an increase over its 2024 EPS that were of A-$5.09.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$5.066.86%
2025A-$4.73-7.02%
2024A-$5.09-16.82%
2023A-$6.12-33.12%
2022A-$9.1560%
2021A-$5.7255.04%
2020A-$3.69207.14%
2019A-$1.20-19.81%
2018A-$1.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
A-$4.01-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A-$3.55-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA